Skip to content

Clinical Study on the Improvement of Eyelash Volume (Area), Length, and Thickness with [LashGlo 2%] Compared to a Control Product

Clinical Study on the Improvement of Eyelash Volume (Area), Length, and Thickness with [LashGlo 2%] Compared to a Control Product

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010976
Enrollment
56
Registered
2025-09-03
Start date
2024-09-11
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : This study is a bilateral study conducted with contributions from the same test subjects, and the test group and control group have overlapping participants. After washing the face twice a da

Sponsors

Dermacle, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Female aged 19 and above 2) Individuals who understand the test content and voluntarily completes and signs the consent form to participate in the test 3) Healthy individuals without acute or chronic physical diseases, including skin diseases 4) Individuals who can be monitored during the study period

Exclusion criteria

Exclusion criteria: 1) Individuals who have had perms, extensions, or other procedures done to the eyelash area 2) Individuals who have applied local hair growth agents, hair tonics, or hair growth agents in the past month 3) Female who are pregnant, breast feeding or planning pregnancy 4) Individuals who have abnormal skin findings such as moles, acne, erythema, or telangiectasia on the test area 5) Individuals who have infectious skin diseases 6) Individuals who have allergies or hypersensitive skin 7) Individuals who are sensitive to cosmetics, medications, or normal light exposure 8) Individuals who have received systemic steroids or phototherapy within 1 month of participating in the study 9) Individuals with mental illness or intellectual disabilities. 10) Individuals who have used topical steroid-containing skin preparations for more than 1 month for the treatment of skin diseases 11) Individuals who have not passed 3 months after participating in the same study 12) Other individuals who are considered unsuitable for the study by the principal investigator

Design outcomes

Primary

MeasureTime frame
eyelash volume (area);eyelash length;eyelash thicknes

Secondary

MeasureTime frame
adverse reactions

Countries

Korea, Republic of

Contacts

Public ContactJeong YunJi

Dermacle, Inc.

dbswl4189@naver.com+82-31-895-4845

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026